Publications Print Park JH, Breitinger SA, Savitz ST, Gardea-Resendez M, Singh B, Williams MD, Frye MA. Delays in bipolar depression treatment in primary care vs. integrated behavioral health and specialty care. J Affect Disord. 2025 Jan 15; 369:404-410 Epub 2024 Oct 09 View PubMed Sara JDS, Rajai N, Breitinger S, Medina-Inojosa B, Lerman LO, Lopez-Jimenez F, Lerman A. Peripheral Endothelial Dysfunction Is Associated With Incident Major Depressive Disorder. J Am Heart Assoc. 2024 Nov 5; 13 (21):e036812 Epub 2024 Nov 04 View PubMed Gardea-Resendez M, Breitinger S, Walker A, Harper L, Xiong A, Stoppel C, Volety RM, Raman J, Byun JS, Langholm C, Goes FS, Zandi PP, Torous J, Frye MA. Digital Technologies Tracking Active and Passive Data Collection in Depressive Disorders: Lessons Learned From a Case Series. J Psychiatr Pract. 2024 Nov 1; 30 (6):434-439 Epub 2024 Nov 01 View PubMed Park JH, Kummerlowe MN, Breitinger S, Allen ND, Morgan RJ. "Super Second," a Unique, Growth-Oriented Residency Rotation Supporting Intern Integration. Acad Psychiatry. 2024 Oct; 48 (5):441-444 Epub 2024 Feb 05 View PubMed Frye MA, Singh B, Breitinger SA, Oesterle TS. Selective Serotonin Reuptake Inhibitor Discontinuation for Psilocybin Treatment and Contributions to Alcohol Addiction Relapse: A Cautionary Tale. J Clin Psychiatry. 2024 Aug 26; 85 (3) View PubMed Oesterle TS, Hall-Flavin DK, Bormann NL, Loukianova LL, Fipps DC, Breitinger SA, Gilliam WP, Wu T, da Costa SC, Arndt S, Karpyak VM. Therapeutic Content of Mobile Phone Applications for Substance Use Disorders: An Umbrella Review. Mayo Clin Proc Digit Health. 2024 Jun; 2 (2):192-206 Epub 2024 Apr 11 View PubMed Oesterle TS, Bormann NL, Ochal DA, Arndt S, Breitinger SA. Transitioning Virtual-Only Group Therapy for Substance Use Disorder Patients to a Hybrid Model. Subst Abuse Rehabil. 2024; 15:73-78 Epub 2024 Apr 23 View PubMed Langholm C, Breitinger S, Gray L, Goes F, Walker A, Xiong A, Stopel C, Zandi PP, Frye MA, Torous J. Using data processing to understand inconsistency in smartphone behavior among patients with serious mental illness: results of a digital phenotyping biomarker study. Biomarkers in Neuropsychiatry. 2024; 11:100105 Breitinger S, Gardea-Resendez M, Langholm C, Xiong A, Laivell J, Stoppel C, Harper L, Volety R, Walker A, D'Mello R, Byun AJS, Zandi P, Goes FS, Frye M, Torous J. Digital Phenotyping for Mood Disorders: Methodology-Oriented Pilot Feasibility Study. J Med Internet Res. 2023 Dec 29; 25:e47006 View PubMed Langholm C, Breitinger S, Gray L, Goes F, Walker A, Xiong A, Stopel C, Zandi P, Frye MA, Torous J. Classifying and clustering mood disorder patients using smartphone data from a feasibility study. NPJ Digit Med. 2023 Dec 21; 6 (1):238 View PubMed Zolnour A, Eldredge CE, Faiola A, Yaghoobzadeh Y, Khani M, Foy D, Topaz M, Kharrazi H, Fung KW, Fontelo P, Davoudi A, Tabaie A, Breitinger SA, Oesterle TS, Rouhizadeh M, Zonnor Z, Moen H, Patrick TB, Zolnoori M. A risk identification model for detection of patients at risk of antidepressant discontinuation. Front Artif Intell. 2023; 6:1229609 Epub 2023 Aug 24 View PubMed Oesterle TS, Karpyak VM, Coombes BJ, Athreya AP, Breitinger SA, Correa da Costa S, Dana Gerberi DJ. Systematic review: Wearable remote monitoring to detect nonalcohol/nonnicotine-related substance use disorder symptoms. Am J Addict. 2022 Nov; 31 (6):535-545 Epub 2022 Sept 05 View PubMed Kamath CC, Kelpin SS, Patten CA, Rummans TA, Kremers HM, Oesterle TS, Williams MD, Breitinger SA. Shaping the Screening, Behavioral Intervention, and Referral to Treatment (SBIRT) Model for Treatment of Alcohol Use Disorder in the COVID-19 Era. Mayo Clin Proc. 2022 Oct; 97 (10):1774-1779 Epub 2022 July 19 View PubMed Kamath CK, Kelpin SS, Patten CA, Rummans TA, Kremers HM, Oesterle TS, Williams MD, Breitinger SA. Shaping SBIRT To Treat AUD in the COVID-19 Era Mayo Clinic Proceedings. 2022; 97(10):1774-1779. View PubMed Kamath C, Kelpin S, Patten CA, Rummans TA, Maradit H, Oesterle TS, Williams MD, Breitinger S. Shaping the Screening, Behavioral Intervention and Referral to Treatment (SBIRT) Model for Treatment of Alcohol Use Disorder in the COVID 19 era ? (MAYOCLINPROC-D-21-00804R1 ) Mayo Clinic Proceedings. 2022. Park JH, Nuñez NA, Gardea-Resendez M, Gerberi DJ, Breitinger S, Veldic M, Frye MA, Singh B. Short Term Second-Generation Antidepressant Monotherapy in Acute Depressive Episodes of Bipolar II Disorder: A Systematic Review and Meta-Analysis. Psychopharmacol Bull. 2022 May 31; 52(2):45-72. View PubMed Gentry MT, Puspitasari AJ, McKean AJ, Williams MD, Breitinger S, Geske JR, Clark MM, Moore KM, Frye MA, Hilty DM. Clinician Satisfaction with Rapid Adoption and Implementation of Telehealth Services During the COVID-19 Pandemic. Telemed J E Health. 2021 Dec; 27 (12):1385-1392 Epub 2021 Feb 19 View PubMed Shayevitz C, Breitinger S, Lerario MP, Mroczkowski M, Osuji M, Fleischut P, Khan M, Murray J, Wilner P, Sombrotto L. Implementation of a Centralized Telepsychiatry Consult Service in a Multi-Hospital Metropolitan Health Care System: Challenges and Opportunities. J Acad Consult Liaison Psychiatry. 2021 Mar-Apr; 62 (2):193-200 Epub 2020 Sept 11 View PubMed Oesterle TS, Kolla B, Risma CJ, Breitinger SA, Rakocevic DB, Loukianova LL, Hall-Flavin DK, Gentry MT, Rummans TA, Chauhan M, Gold MS. Substance Use Disorders and Telehealth in the COVID-19 Pandemic Era: A New Outlook. Mayo Clin Proc. 2020 Dec; 95 (12):2709-2718 Epub 2020 Oct 21 View PubMed Breitinger S, Gentry MT, Hilty DM. Key Opportunities for the COVID-19 Response to Create a Path to Sustainable Telemedicine Services. Mayo Clin Proc. 2020 Dec; 95 (12):2602-2605 Epub 2020 Oct 01 View PubMed Deferio J, Breitinger S, Khullar D, Sheth A, Pathak J. Social Determinants of Health in Mental Health Care and Research: A Case for Greater Inclusion. Journal of the American Medical Informatics. 2019; 26(8-9):895-899. PST-20467011 Home Publications